Navigation Links
Life Technologies Launches Ion AmpliSeq™ Custom Panels, Unlocking Thousands of Disease-Related Research Samples for Analysis
Date:3/27/2012

TaqMan® assay design pipeline to create optimized gene panels.  Panels can be designed in as little as 2.5 hours for regions up to 250 Kb in size, expanding to 1 Mb later in 2012, and may contain up to 1,536 amplicons per reaction.  Ion Torrent's intuitive data analysis methods enable rapid scaling from analyzing just a few genes to hundreds of genes – all in a single day.

Ion AmpliSeq™ Designer builds upon the well-received Ion AmpliSeq™ Cancer Panel, which has accelerated cancer research for scientists like Dr. Sean Grimmond, Professor at the Queensland Centre for Medical Genomics. Dr. Grimmond said: "We have been using custom AmpliSeq as a means to rapid screen the prevalence of mutations in a series of novel pancreatic cancer genes we have found through exome sequencing as part of the International Cancer Genome Consortium. AmpliSeq is an excellent validating tool in cancer genome studies due to its speed, minimal template requirements and its overall robustness."

Watch an introduction and an in-depth explanation of the Ion AmpliSeq™ Custom Panels and the Ion AmpliSeq™ Designer. For more information, visit www.ampliseq.com.

The above referenced products are for Research Use Only. Not intended for human diagnostics purposes.

About Life Technologies

Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company with customers in more than 160 countries using its innovative solutions to solve some of today's most difficult scientific challenges. Quality and innovation are accessible to every lab with its reliable and easy-to-use solutions spanning the biological spectrum with more than 50,000 products for translat
'/>"/>

SOURCE Life Technologies
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Wound Management Technologies Names Robert Lutz, Jr. as New CEO; Buys Back North American Distribution Rights for CellerateRX® Powder
2. Frost & Sullivans Advanced Medical Technologies Research Tracks Opportunities in Markets Influenced by Dynamic Care Pathways
3. Antibody Drugs: Technologies and Global Markets
4. Novation Releases Its Latest Transcatheter Cardiovascular Therapeutics Report to Help Members Understand and Prepare for New Technologies
5. OriGene Technologies Announces the Release Specificity-Verified UltraMAB™ Antibodies
6. Blue Belt Technologies to Showcase Navio™ PFS System at CAOS UK 2012 Conference in Glasgow, UK
7. Life Technologies Launches GeneArt® Precision TALs
8. BioStorage Technologies to Host Live Webinar on Optimizing the Value of Sample Assets
9. PLC Announces Ministry of Health Approval to Distribute RenalGuard® in Israel Through A.M.I. Technologies, Ltd.
10. Omnicell to Exhibit at Dubai International Pharmaceuticals and Technologies Conference and Exhibition
11. Palatin Technologies Completes Enrollment in Phase 2B Bremelanotide Female Sexual Dysfunction Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 XRpro Sciences, ... drug discovery and development services which features high ... pharmaceutical industry, announced financial results for the year ... C.  Tyson, Chairman of XRpro Sciences commented, "We ... transition from development stage to commercial stage in ...
(Date:3/27/2015)... -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX: ... registered offering of common shares in the ... Offering, the Company issued 7,286,432 common shares at a ... of approximately $1.45 billion. On March 18, 2015, the ... a final prospectus supplement to its effective shelf registration ...
(Date:3/27/2015)... HOLLYWOOD, Calif. , March 27, 2015 ... of life of myeloma patients while working toward prevention ... Higgins (D-NY) for introducing a federal resolution (H. ... of March 2015 as "National Multiple Myeloma Awareness Month." ... living with myeloma worldwide, and more than 110,000 new ...
Breaking Medicine Technology:XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3The International Myeloma Foundation (IMF) Secures the Introduction of a Federal Resolution Recognizing March 2015 as "National Multiple Myeloma Awareness Month" 2
... NEW YORK , June 24 Reportlinker.com announces that a new market research ... , Global Bipolar Disorder ... http://www.reportlinker.com/p0209267/Global-Bipolar-Disorder-Industry.html , ... This report analyzes the worldwide markets for Bipolar Disorder in US$ Million. The report ...
... ALEXANDRIA, Egypt and NORCROSS, Ga. , June ... distribution company, today announced that it has signed an exclusive agreement ... Pharmaplast. , , , ... milestone agreement is the foundation for MediPurpose,s recently launched Wound Care ...
Cached Medicine Technology:Reportlinker Adds Global Bipolar Disorder Industry 2Reportlinker Adds Global Bipolar Disorder Industry 3Reportlinker Adds Global Bipolar Disorder Industry 4Reportlinker Adds Global Bipolar Disorder Industry 5Reportlinker Adds Global Bipolar Disorder Industry 6Reportlinker Adds Global Bipolar Disorder Industry 7Reportlinker Adds Global Bipolar Disorder Industry 8Reportlinker Adds Global Bipolar Disorder Industry 9Reportlinker Adds Global Bipolar Disorder Industry 10Reportlinker Adds Global Bipolar Disorder Industry 11Reportlinker Adds Global Bipolar Disorder Industry 12Reportlinker Adds Global Bipolar Disorder Industry 13Reportlinker Adds Global Bipolar Disorder Industry 14Reportlinker Adds Global Bipolar Disorder Industry 15Reportlinker Adds Global Bipolar Disorder Industry 16MediPurpose® Announces U.S. Distribution Agreement With Pharmaplast, Egyptian Advanced Wound Care OEM 2MediPurpose® Announces U.S. Distribution Agreement With Pharmaplast, Egyptian Advanced Wound Care OEM 3MediPurpose® Announces U.S. Distribution Agreement With Pharmaplast, Egyptian Advanced Wound Care OEM 4
(Date:3/27/2015)... NY (PRWEB) March 27, 2015 Ticket Down is ... Concert in 2015. After a phenomenal and highly successful ... "Nashville" will be going out on tour again in 2015 and ... tour gets underway on April 29th in New York City at ... at the Comerica Theatre on May 10th. , Fans of the ...
(Date:3/27/2015)... UK (PRWEB) March 27, 2015 DrugDev ... Melissa (Liss) Easy was named to the 2015 Philadelphia ... Under 40 list spotlights 40 dynamic, up-and-coming leaders less ... and community involvement. Winners are honored at an awards ... of the Philadelphia Business Journal. , Lyn Kremer, Publisher ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 GenSight, the ... has appointed Sean Fitzgerald, a former technology and financial ... Officer and Interim Chief Financial Officer. , Mr Fitzgerald ... technology innovator, EverFi, backed by Amazon founder and CEO ... Evan Williams. Prior to EverFi, he was a Senior ...
(Date:3/27/2015)... March 27, 2015 Operatic contenders and ... greatness on April 17th. The universally acclaimed baritone Sherrill ... 9th annual Opera Idol at The Merion in Evanston. ... which has drawn aspiring opera singers from around the ... some of the finest young talent in the country,” ...
(Date:3/27/2015)... 27, 2015 Since September 2014, the country ... comeback tour after having been in retirement for a period ... the performer to return to touring, and concert events have ... Omaha will likely sell out for the two shows recently ... to view the inventory of discounted Garth Brooks tickets ...
Breaking Medicine News(10 mins):Health News:Nashville Live in Concert Tickets in New York, Boston, Washington, DC, Chicago, Minneapolis, San Francisco, Los Angeles and Phoenix Now On Sale at TicketDown.com 2Health News:DrugDev Founder Melissa Easy is 2015 Philadelphia Business Journal 40 Under 40 Honoree 2Health News:GenSight Appoints Former Technology Executive as Chief Operating Officer 2Health News:Opera Idol Competition At The Merion In Evanston 2Health News:Garth Brooks Tickets for Omaha: BuyCheapTicketsToEvents.com Draws Customers by Discounting Prices on 2015 Tickets for Garth Brooks’ Tour Stops at CenturyLink Center 2
... Inc.,(OTC Bulletin Board: ENEI) today announced that its ... presentation at the Roth,Capital 20th Annual OC Growth ... February 21st. The conference is being held over ... Dana Point, California. The,conference will feature presentations from ...
... /PRNewswire-FirstCall/ - The Westaim Corporation,announced today that for the year ... million, or 62 cents per share, on revenues of $31.8,million ... cents per share, on,revenues of $27.6 million in the previous ... posted a net loss of $26.8 million, or 28,cents per ...
... interpersonal conflicts had more health problems, study found , , FRIDAY, ... along with others is more than a key to pleasant ... health. , Researchers who studied a survey of almost ... their relatives, friends and neighbors were less likely to report ...
... Webcast on February 21st at 12:00 p.m. Pacific Time ... (Amex: SYI ) announced today that Noah Berkowitz, ... present at,the Roth 20th Annual OC Growth Stock Conference ... (3:00 p.m. Eastern time) at the Ritz,Carlton Hotel in ...
... international study published today finds that some alternative therapies ... choices for managing most common neck pain than many ... best options for relief are exercises, education, neck mobilization, ... such as neck collars and ultrasound are not recommended. ...
... concept that chronic pain is a disease in its ... at physical, psychological, and environmental components of this major ... pain medicine expert. , Michael J Cousins AM, MD, ... Institute at the University of Sydney, Royal North Shore ...
Cached Medicine News:Health News:Ener1 to Present at February Roth Capital 20th Annual OC Growth Stock Conference 2Health News:Westaim announces 2007 year-end results 2Health News:Westaim announces 2007 year-end results 3Health News:Westaim announces 2007 year-end results 4Health News:Westaim announces 2007 year-end results 5Health News:Westaim announces 2007 year-end results 6Health News:Westaim announces 2007 year-end results 7Health News:Westaim announces 2007 year-end results 8Health News:Westaim announces 2007 year-end results 9Health News:Westaim announces 2007 year-end results 10Health News:Westaim announces 2007 year-end results 11Health News:Westaim announces 2007 year-end results 12Health News:Unlike Fine Wine, Crabby People Don't Age Well 2Health News:Unlike Fine Wine, Crabby People Don't Age Well 3Health News:Synvista Therapeutics to Present at the Roth 20th Annual OC Growth Stock Conference 2Health News:Synvista Therapeutics to Present at the Roth 20th Annual OC Growth Stock Conference 3Health News:7-year neck pain study sheds light on best care 2Health News:7-year neck pain study sheds light on best care 3Health News:7-year neck pain study sheds light on best care 4Health News:Chronic pain should be considered a disease 2
Bio-Rad's Genetic Systems HIV-1/HIV-2 PLUS O EIA is a unique assay that detects the broadest range of HIV....
The humidity chamber maintains a moist environment during immunostaining procedures as well as other laboratory procedures requiring controlled incubation steps....
Thermostatically controlled, large capacity surface to quickly evaporate water and solvents from slides and mounting media....
Liquichek Blood Gas Plus CO-Oximeter Control (IL Synthesis Series) is a combination control for use in monitoring the performance of blood gas, ion-selective electrode, biosensor and CO-Oximetry anal...
Medicine Products: